In addition to application, the market taxonomy distinguishes Rosa Canina Flower Extract by type, a classification that influences processing cost, purity, and end‑use suitability. The primary extraction methods include solvent extraction, which yields a high‑concentration liquid extract but may retain residual solvents; supercritical CO₂ extraction, delivering a solvent‑free, standardized powder with superior bioactive retention; and aqueous extraction, favored for food‑grade products due to its water‑based nature. Each method generates sub‑product forms: liquid concentrates (typically 10–20 % w/w active), dry powders (standardized to 5–10 % vitamin C equivalents), and encapsulated extracts designed for controlled release in nutraceutical capsules. Solvent‑derived liquids dominate the cosmetics segment, accounting for roughly 45 % of type‑related revenue, while supercritical powders are preferred in pharmaceuticals, contributing about 35 %. Aqueous extracts and encapsulated formats together represent the remaining 20 %, serving food & beverage and personal‑care niches respectively. This detailed Rosa Canina Flower Extract segmentation by type clarifies how extraction technology and product form together shape the market’s quantitative profile.